ES2387682T3 - Utilización de un undecapéptido cíclico para la preparación de un medicamento administrable durante situaciones isquémicas miocárdicas - Google Patents

Utilización de un undecapéptido cíclico para la preparación de un medicamento administrable durante situaciones isquémicas miocárdicas Download PDF

Info

Publication number
ES2387682T3
ES2387682T3 ES06704161T ES06704161T ES2387682T3 ES 2387682 T3 ES2387682 T3 ES 2387682T3 ES 06704161 T ES06704161 T ES 06704161T ES 06704161 T ES06704161 T ES 06704161T ES 2387682 T3 ES2387682 T3 ES 2387682T3
Authority
ES
Spain
Prior art keywords
formula
cyclicdecapeptide
use according
cyclic undecapeptide
reperfusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06704161T
Other languages
English (en)
Spanish (es)
Inventor
Pietro Scalfaro
Jean-Maurice Dumont
Grégoire VUAGNIAUX
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Application granted granted Critical
Publication of ES2387682T3 publication Critical patent/ES2387682T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES06704161T 2005-01-10 2006-01-10 Utilización de un undecapéptido cíclico para la preparación de un medicamento administrable durante situaciones isquémicas miocárdicas Expired - Lifetime ES2387682T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05000357 2005-01-10
EP05000357 2005-01-10
PCT/EP2006/050140 WO2006072639A1 (fr) 2005-01-10 2006-01-10 Utilisation d’un undecapeptide cyclique pour la preparation d’un médicament administrable lors de situations ischemiques myocardiques

Publications (1)

Publication Number Publication Date
ES2387682T3 true ES2387682T3 (es) 2012-09-28

Family

ID=34933239

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06704161T Expired - Lifetime ES2387682T3 (es) 2005-01-10 2006-01-10 Utilización de un undecapéptido cíclico para la preparación de un medicamento administrable durante situaciones isquémicas miocárdicas

Country Status (9)

Country Link
US (1) US8889629B2 (https=)
EP (1) EP1853296B1 (https=)
JP (1) JP2008526816A (https=)
DK (1) DK1853296T5 (https=)
ES (1) ES2387682T3 (https=)
PL (1) PL1853296T3 (https=)
PT (1) PT1853296E (https=)
SI (1) SI1853296T1 (https=)
WO (1) WO2006072639A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023948A1 (en) * 2006-05-04 2009-02-18 Michel Ovize Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
EP2967567B1 (en) * 2013-03-15 2022-08-24 Boston Scientific Scimed, Inc. System for controlling a tissue-stapling operation with pressurized fluid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999019471A1 (en) * 1997-10-16 1999-04-22 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
PT1056729E (pt) * 1998-02-27 2005-04-29 Pfizer Prod Inc Derivados de n-[ciclo di- ou tri-aza di-insaturado de cinco membros substituido) carbonil] guanidina para o tratamento de isquemia
PT1091975E (pt) * 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
US6790935B1 (en) * 1999-02-05 2004-09-14 Debiopharm S.A. Cyclosporin derivatives and method for the production of said derivatives

Also Published As

Publication number Publication date
EP1853296A1 (fr) 2007-11-14
EP1853296B1 (fr) 2012-06-20
US8889629B2 (en) 2014-11-18
DK1853296T5 (da) 2013-03-18
JP2008526816A (ja) 2008-07-24
SI1853296T1 (sl) 2012-10-30
WO2006072639A1 (fr) 2006-07-13
DK1853296T3 (da) 2012-09-03
PT1853296E (pt) 2012-09-26
US20090023640A1 (en) 2009-01-22
PL1853296T3 (pl) 2012-12-31

Similar Documents

Publication Publication Date Title
ES2906865T3 (es) Uso de sulfatos de colesterol oxigenados (OCS) para tratar la insuficiencia hepática aguda
US20070042016A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
AU652992B2 (en) Method and composition for treating reperfusion injury
US20070093748A1 (en) Methods and systems for treating injured cardiac tissue
ES2906262T3 (es) Composiciones para el tratamiento de la autodigestión
ES2387682T3 (es) Utilización de un undecapéptido cíclico para la preparación de un medicamento administrable durante situaciones isquémicas miocárdicas
RU2615767C2 (ru) Способ лечения сердечной недостаточности и поражения нервных клеток
ES2651492T3 (es) Composición acuosa pulverizable que comprende trinitrato de glicerilo
ES2361915T3 (es) Utilización de la betaína para el tratamiento de la claudicación intermitente.
Pokorný et al. Ventricular assist devices in heart failure: how to support the heart but prevent atrophy?
CN115137718A (zh) 一种制备恢复心脏肥厚病中减低的CNPase活性的药物的方法
CN101933897B (zh) 注射用重组人血管内皮抑制素温度敏感性凝胶组合物
JP2008520681A5 (https=)
WO2016086327A1 (es) Formulación antioxidante inyectable de uso intravenoso de ascorbato de sodio - en altas dosis, n-acetilcisteína, y deferoxamina; método de administración y uso en prevenir daño por reperfusión; y kit
WO2023131142A1 (zh) 一种稳定溶液、制备方法、应用、药物组合物及试剂盒
KR20090010176A (ko) 아데노신 및 이노신을 병용하는, 진단 및 치료를 위한 조성물, 방법 및 키트
CN111939122A (zh) 肺动脉高压靶向治疗的速效制剂
ES2946005T3 (es) Uso de GHRP-6 como medicamento cardioprotector y de restauración cardíaca tardía
ES2346755T3 (es) Uso de acetato de megestrol para mejorar la funcion cardiaca y el tratamiento de la insuficiencia cardiaca.
CA2160689C (en) New method of treatment
CN103083323A (zh) 盐酸法舒地尔作为制备促进骨髓间充质干细胞在体存活和修复药物的应用及其制剂
RU2798118C1 (ru) Способ получения инъекционной фармацевтической композиции для животных на основе метилурацила (диоксометилтетрагидропиримидина)
PT1539213E (pt) Terapêuticas cardioprotectoras baseadas na eliminação enzimática de peróxidos de lípidos por aleno óxido sintase
CN114146091B (zh) 瑞德西韦在制备预防和治疗再灌注损伤药物中的应用
EA014753B1 (ru) Средство для предотвращения прогрессирования апоптотических изменений в клетках различных органов и их перехода в некротическое поражение